Predictors and complications of blood transfusion in total hip and knee arthroplasty

Journal of Arthroplasty

Volumn 29, Issue 9 SUPPL., 2014, Pages 189-192

  Frisch, Nicholas B ^a   Wessell, Nolan M ^a   Charters, Michael A ^a   Yu, Stephen ^b   Jeffries, James J ^a   Silverton, Craig D ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood management; Complications; Total hip arthroplasty; Total knee arthroplasty; Transfusion

Indexed keywords

CREATININE; HEMOGLOBIN; INFUSION FLUID;

AGE; AGED; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; FEMALE; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPERATION DURATION; OPERATIVE BLOOD LOSS; PREDICTION; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SURGICAL INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; BLOOD; BLOOD LOSS, SURGICAL; CLINICAL TRIAL; HIP ARTHROPLASTY; KNEE ARTHROPLASTY; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BODY MASS INDEX; CREATININE; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURGICAL WOUND INFECTION;

EID: 84921633471     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2014.03.048     Document Type: Article

References (20)

1. Kurtz S., Ong K., Lau E., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg 2007, 89(4):780.
2. Bierbaum B., Callaghan J., Galante J., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg 1999, 81-A(1):2.
3. Lemos M., Healy W. Blood transfusions in orthopaedic operations. J Bone Joint Surg 1996, 78-A(8):1260.
4. Bong M.R., Patel V., Chang E., et al. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2004, 19(3):281.
5. Forbes J., Anderson M., Anderson G., et al. Blood transfusion costs: a multicenter study. Transfusion 1991, 31(4):318.
6. Green W.S., Toy P., Bozic K.J. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty. J Arthroplasty 2010, 25(1):93.
7. Browne J.A., Adib F., Brown T.E., et al. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty 2013, 28(8 Suppl):34.
8. Knight J.L., Sherer D., Guo J. Blood transfusion strategies for total knee arthroplasty: minimizing autologous blood wastage, risk of homologous blood transfusion, and transfusion cost. J Arthroplasty 1998, 13(1):70.
9. Wells A., Mounter P., Chapman C., et al. Where does the blood go? Prospective observational study of red cell transfusion in North England. Br Med J 2002, 325:803.
10. Nuttall G., Santrach P., Oliver W.J., et al. The predictors of red cell transfusions in total hip arthroplasties. Transfusion 1996, 36(2):144.
11. Guerin S., Collins C., Kapoor H., et al. Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty. Transfus Med 2007, 17:37.
12. Noticewala M.S., Nyce J.D., Wang W., et al. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty 2012, 27(6):961.
13. Pierson J., Hannon T., Earles D. A blood conservation algorithm to reduce blood transfusion after total hip and knee arthroplasty. J Bone Joint Surg 2004, 86-A(7):1512.
14. Rosencher N., Kerkkamp H.E., Macheras G., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003, 43(4):459.
15. Jans O., Jorgensen C., Kehlet H., et al. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty. Transfusion 2013, 54(3):717.
16. Keating E.M., Ritter M.A. Transfusion options in total joint arthroplasty. J Arthroplasty 2002, 17(4 Suppl. 1):125.
17. Feagan B., Wong C., Kirkley A., et al. Erythropoietin reduced the need for allogeneic blood transfusion in total hip joint arthroplasty. J Bone Joint Surg 2001, 83-A(5):788.
18. Feagan B., Wong C., Kirkley A., et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty: a randomized, controlled trial. Ann Intern Med 2000, 133:845.
19. Januel J., Chen G., Ruffieux C., et al. Symptomatic in-hospital DVT and PE following hip and knee arthroplasty among patients receiving recommended prophylaxis. J Am Med Assoc 2012, 307(3):294.
20. Pola E., Papaleo P., Santoliquido A., et al. Clinical factors associated with an increased risk of perioperative blood transfusion in non-anemic patients undergoing total hip arthroplasty. J Bone Joint Surg 2004, 86-A(1):57.